Margins matter. The more CryoLife (NYS: CRY) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy ...

ATLANTA -- The price of safety turned out to be $27.2 million for CryoLife, a human-tissue processor that ran afoul of the federal government. That's how much a recall ordered by the Food and Drug ...

ATLANTA, Oct. 11, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2012 third ...

CryoLife (CRY) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a year ago. These figures are ...

CryoLife, Inc. CRY +2.05% , a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced it has entered into a credit facility with GE Capital, Healthcare ...

CryoLife (NYS: CRY) met its estimates last quarter, but investors hope that it will beat them this quarter. The company will unveil its latest earnings on Thursday. CryoLife preserves and distributes ...

ATLANTA, Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-nside ...

Listed, Atlanta-based tissue processing and medical device firm CryoLife Inc. will invest $3.5 million in ValveXchange Inc., a private medical device company spun from Cleveland Clinic. CryoLife will ...

CryoLife, Inc. CRY announced the signing of a distribution and credit facility agreement with Israel-based endovascular stent graft system developer, Endospan. The alliance will add NEXUS (the only ...

Ken Alesescu was an avid hiker, skier and scuba diver. Now, as CBS News Correspondent Vince Gonzales reports, just getting to physical therapy is a challenge for the 50-year-old father of two. Federal ...

Keep your eye on margins. Margins matter. The more CryoLife (NYSE: CRY) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...